Chemokine Receptors and Drug Discovery--SMR meeting. 11 March 2004, Horsham, UK.
Bhalay
Gurdip
G
Novartis Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, UK. gurdip.bhalay@pharma.novartis.com
Dunstan
Andrew
A
D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D065100:CCR5 Receptor Antagonists; D018925:Chemokines / Q000494:pharmacology / Q000502:physiology; D015195:Drug Design; D006801:Humans; D010600:Pharmacology; D054397:Receptors, CCR3; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000187:drug effects*; D023062:Receptors, Interleukin-8A / Q000037:antagonists & inhibitors
D019380:Anti-HIV Agents; D000911:Antibodies, Monoclonal; C515350:CCR3 protein, human; D065100:CCR5 Receptor Antagonists; D018925:Chemokines; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; D023062:Receptors, Interleukin-8A